Skip to content

A study on efficacy and safety of total peritoneal resection in surgical treatment of advanced ovarian cancer

A Phase2 Trial of Total Parietal Peritonectomy in Primary Debulking Surgery for Advanced Ovarian Neoplasm - TPP Phase 2 Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048925
Enrollment
40
Registered
2022-09-20
Start date
2022-09-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Total Parietal Peritonectomy

Sponsors

The Jikei University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: * Primary diagnosis of ovarian cancer FIGO stage IIIB-IIIC * Macroscopic complete resection is possible with PDS based on preoperative examination, staging laparoscopy, and intraoperative findings during PDS * Histology is diagnosed as High Grade Serous Carcinoma or Endometrioid Carcinoma by tissue biopsy during staging laparoscopy * Patients who have given their signed and written informed consent * Age: 18 - 70 years * Good performance status (ECOG 0/1)

Exclusion criteria

Exclusion criteria: * Borderline tumors * There are suspicious lymph nodes (bulky nodes) in preoperative examination and intraoperative findings and systematic retroperitoneal lymphadenectomy is required * Secondary invasive neoplasms in the last 5 years (However, it is permissible if the possibility of recurrence within 2 years after registration is sufficiently low) * Neoadjuvant chemotherapy * Any significant medical reasons, age or performance status that will not allow to perform the study procedures * Dementia or significantly altered mental status that would prohibit the understanding and giving of informed consent

Design outcomes

Primary

MeasureTime frame
2-year RFS rate

Countries

Japan

Contacts

Public ContactKota Yokosu

The Jikei University School of Medicine Department of Obstetrics and Gynecology

kouta_yokosu@yahoo.co.jp03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026